This inventor holds 1 USPTO granted patent. Top assignee: Ben-Gurion University of the Negev Research and Development Authority. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Israel Patla: Innovator in Transfetal Membrane Transport
Introduction
Israel Patla is a notable inventor based in Beer-Sheva, Israel. He has made significant contributions to the field of medical technology, particularly in the area of fetal membrane transport. His innovative work has the potential to enhance medical procedures related to gestational sacs.
Latest Patents
Israel Patla holds 1 patent for his invention titled "System and method for transfetal (amnion-chorion) membranes transport." This invention provides a system and method for trans-fetal membranes transport. A source of ultrasound sonication is utilized to deliver ultrasound sonication to fetal membranes, enhancing their permeability. In one embodiment, a device is designed to collect substances transported from the interior of the gestational sac to the exterior, such as amniotic or coelomic fluid. In another embodiment, a device is employed to deliver one or more substances, such as a drug, to an external surface of the fetal membranes.
Career Highlights
Israel Patla is associated with the Ben-Gurion University of the Negev Research and Development Authority. His work at this institution has allowed him to explore and develop innovative solutions in the medical field. His research focuses on improving fetal health and medical interventions.
Collaborations
Some of his notable coworkers include Joseph Kost and Avraham Schroeder. Their collaborative efforts contribute to the advancement of research and development in the field of fetal medicine.
Conclusion
Israel Patla's contributions to the field of fetal membrane transport demonstrate his commitment to innovation and medical advancement. His work has the potential to significantly impact fetal health and medical practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
